BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

CAPSTONE INVESTMENT ADVISORS, LLC's Holding History (CIK: 0001426196)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 18,358 Value ($000) $139 Avg Close $8.33 Range $7.42 - $9.23

Q2 2024

Shares 26,742 Value ($000) $165 Avg Close $5.52 Range $4.03 - $6.99

Q4 2023

Shares 18,650 Value ($000) $112 Avg Close $5.79 Range $4.83 - $7.06

Q2 2023

Shares 17,164 Value ($000) $121 Avg Close $8.02 Range $6.87 - $9.07

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	18,358	$139	$8.33	$7.42 - $9.23
Q2 2024	26,742	$165	$5.52	$4.03 - $6.99
Q4 2023	18,650	$112	$5.79	$4.83 - $7.06
Q2 2023	17,164	$121	$8.02	$6.87 - $9.07